Emergent BioSolutions Inc (EBS)
9.48
+0.08
(+0.85%)
USD |
NYSE |
Nov 22, 16:00
9.41
-0.07
(-0.74%)
After-Hours: 18:57
Emergent BioSolutions Total Liabilities (Quarterly): 969.40M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 969.40M |
| June 30, 2024 | 1.127B |
| March 31, 2024 | 1.140B |
| December 31, 2023 | 1.174B |
| September 30, 2023 | 1.196B |
| June 30, 2023 | 1.222B |
| March 31, 2023 | 1.747B |
| December 31, 2022 | 1.779B |
| September 30, 2022 | 1.459B |
| June 30, 2022 | 1.222B |
| March 31, 2022 | 1.205B |
| December 31, 2021 | 1.346B |
| September 30, 2021 | 1.345B |
| June 30, 2021 | 1.372B |
| March 31, 2021 | 1.377B |
| December 31, 2020 | 1.436B |
| September 30, 2020 | 1.365B |
| June 30, 2020 | 1.267B |
| March 31, 2020 | 1.204B |
| December 31, 2019 | 1.239B |
| September 30, 2019 | 1.299B |
| June 30, 2019 | 1.332B |
| March 31, 2019 | 1.166B |
| December 31, 2018 | 1.218B |
| September 30, 2018 | 206.97M |
| Date | Value |
|---|---|
| June 30, 2018 | 200.54M |
| March 31, 2018 | 187.19M |
| December 31, 2017 | 157.90M |
| September 30, 2017 | 360.49M |
| June 30, 2017 | 349.88M |
| March 31, 2017 | 341.22M |
| December 31, 2016 | 373.91M |
| September 30, 2016 | 384.40M |
| June 30, 2016 | 383.79M |
| March 31, 2016 | 368.92M |
| December 31, 2015 | 377.47M |
| September 30, 2015 | 371.24M |
| June 30, 2015 | 381.07M |
| March 31, 2015 | 379.97M |
| December 31, 2014 | 385.49M |
| September 30, 2014 | 356.15M |
| June 30, 2014 | 349.48M |
| March 31, 2014 | 345.76M |
| December 31, 2013 | 137.46M |
| September 30, 2013 | 128.61M |
| June 30, 2013 | 106.53M |
| March 31, 2013 | 102.58M |
| December 31, 2012 | 122.10M |
| September 30, 2012 | 111.61M |
| June 30, 2012 | 104.62M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
969.40M
Minimum
Sep 2024
1.779B
Maximum
Dec 2022
1.310B
Average
1.253B
Median
Total Liabilities (Quarterly) Benchmarks
| Geovax Labs Inc | 2.608M |
| Tonix Pharmaceuticals Holding Corp | 20.78M |
| Abbott Laboratories | 34.33B |
| Insulet Corp | 1.907B |
| SIGA Technologies Inc | 25.91M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.478B |
| Shareholders Equity (Quarterly) | 508.40M |
| Debt to Equity Ratio | 1.303 |
| Current Ratio | 2.877 |
| Net Debt Paydown Yield | 10.66% |